benzbromarone has been researched along with Brain Vascular Disorders in 2 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This research aimed to study the relation of ischemic cerebrovascular disease with benzbromarone use among persons with gout-related disorders." | 8.31 | The risk of ischemic cerebrovascular disease associated with benzbromarone use in gout people: A retrospective cohort study in Taiwan. ( Hwang, BF; Kuo, YH; Lai, SW; Liao, KF; Liu, CS, 2023) |
| " This research aimed to study the relation of ischemic cerebrovascular disease with benzbromarone use among persons with gout-related disorders." | 4.31 | The risk of ischemic cerebrovascular disease associated with benzbromarone use in gout people: A retrospective cohort study in Taiwan. ( Hwang, BF; Kuo, YH; Lai, SW; Liao, KF; Liu, CS, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, SW | 1 |
| Liao, KF | 1 |
| Kuo, YH | 1 |
| Hwang, BF | 1 |
| Liu, CS | 1 |
| Murakami, H | 1 |
| Shimamoto, K | 1 |
1 review available for benzbromarone and Brain Vascular Disorders
| Article | Year |
|---|---|
[Essential hypertension].
Topics: Allopurinol; Antihypertensive Agents; Benzbromarone; Cerebrovascular Disorders; Humans; Hypertension | 2003 |
1 other study available for benzbromarone and Brain Vascular Disorders
| Article | Year |
|---|---|
The risk of ischemic cerebrovascular disease associated with benzbromarone use in gout people: A retrospective cohort study in Taiwan.
Topics: Benzbromarone; Cerebrovascular Disorders; Gout; Gout Suppressants; Humans; Retrospective Studies; Ta | 2023 |